[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f1mdj9803m8uea":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":4,"approvalsBeforeLoe":23,"products":24,"patents":33,"exclusivities":34,"paragraphIv":35,"catalysts":37},"ORTHO TRI-CYCLEN LO","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","janssen-pharms",[20],"021241","none",1,0,[25],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"021241-001","001","TABLET","ORAL-28","0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2002-08-22","DISCN",[],[],{"asOf":12,"firstFiled":12,"entries":36},[],[38],{"id":39,"type":40,"eventDate":41,"detectedAt":42,"product":26,"payload":43,"historical":4},2396,"ANDA_APPROVED","2026-09-23","2026-10-25T00:13:35.709Z",{"route":29,"andaNo":44,"sponsor":45,"dosageForm":28,"ingredient":16},"220876","ANNORA PHARMA"]